West Pharma (WST) Tops Q3 EPS by 8c, Revenues Beat; Raises FY19 EPS/Revenue Guidance Above Consensus

October 24, 2019 6:15 AM

West Pharma (NYSE: WST) reported Q3 EPS of $0.79, $0.08 better than the analyst estimate of $0.71. Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found